In consultation with FDA, McNeil Consumer Health, Division of McNeil-PPC Inc., has initiated a wholesale and retail level recall of Tylenol Cold Multi-Symptom liquid products; Children?s Benadryl Allergy Fastmelt Tablets, in cherry and grape flavors; Junior Strength Motrin Caplets, 24 count; and Rolaids Extra Strength Softchews, Cherry Flavor 36-count package.
In consultation with FDA, McNeil Consumer Health, Division of McNeil-PPC Inc., has initiated a wholesale and retail level recall of:
These recalls are not being undertaken on the basis of adverse events. No action is required by consumers or healthcare providers and consumers can continue to use the products.
Three Tylenol Cold Multi-Symptom liquid products, sold in the United States, will have labeling updates. An internal review revealed that information about the presence of alcohol from flavoring agents was noted as an inactive ingredient listed on the package, but not on the front panel of the product. Certain flavoring agents contribute small (
Children’s Benadryl Allergy Fastmelt Tablets in cherry and grape flavors, distributed in the United States, Belize, Barbados, Canada, Puerto Rico, St. Martin, and St. Thomas, and all product lots of Junior Strength Motrin Caplets, 24 count, that were distributed in the United States, were recalled after a review. The review revealed insufficiencies in the development of the manufacturing process.
Finally, one product lot of Rolaids Extra Strength Softchews, Cherry Flavor, 36-count package distributed in the United States, was also recalled. The recall was initiated as a precaution following consumer complaints of an uncharacteristic consistency or texture, traced to crystallized sugar in the product.
FDA Clears Phase 2 Trial of Cannabis in PTSD
November 20th 2024After a three-year negotiation, the FDA has dropped its objection to allowing patients to self-titrate dosing of smoked cannabis. But regulators want to see additional information about the device that will be used for inhalation.
Read More